Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Sandya Liyanarachchi
Affiliation
The Ohio State University Comprehensive Cancer Center, Comprehensive Cancer Center
ORCID
Career Start Year
2002
Papers
99
H Index
48
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
38062767
Presumed Pathogenic Germ Line and Somatic Variants in African American Thyroid Cancer.
Thyroid
2024
38062777
<i>PDPR</i> Gene Variants Predisposing to Papillary Thyroid Cancer.
Thyroid
2024
37051697
The <i>RCAN1.4</i> Metastasis Suppressor Is Hypermethylated at Intron 1 in Thyroid Cancer.
Thyroid
2023
33943044
A novel essential splice site variant in SPTB in a large hereditary spherocytosis family.
Mol Genet Genomic Med
2021
33527407
Multiethnic genome-wide association study of differentiated thyroid cancer in the EPITHYR consortium.
Int J Cancer
2021
34916535
Author Correction: GWAS of thyroid stimulating hormone highlights the pleiotropic effects and inverse association with thyroid cancer.
Nat Commun
2021
34238982
Transcriptome analysis discloses dysregulated genes in normal appearing tumor-adjacent thyroid tissues from patients with papillary thyroid carcinoma.
Sci Rep
2021
31095041
Estimated risk of progression of lentigo maligna to lentigo maligna melanoma.
Melanoma Res
2020
31928178
A Truncating Germline Mutation of <i>TINF2</i> in Individuals with Thyroid Cancer or Melanoma Results in Longer Telomeres.
Thyroid
2020
32051256
Variants in <i>LRRC34</i> reveal distinct mechanisms for predisposition to papillary thyroid carcinoma.
J Med Genet
2020
33203992
Characterizing the function of EPB41L4A in the predisposition to papillary thyroid carcinoma.
Sci Rep
2020
32769997
GWAS of thyroid stimulating hormone highlights pleiotropic effects and inverse association with thyroid cancer.
Nat Commun
2020
32132206
Assessing thyroid cancer risk using polygenic risk scores.
Proc Natl Acad Sci U S A
2020
30291333
Genome-wide association study identifies an acute myeloid leukemia susceptibility locus near BICRA.
Leukemia
2019
31375516
Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia.
Clin Cancer Res
2019
30877237
Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome.
J Med Genet
2019
30957677
Identification of Rare Variants Predisposing to Thyroid Cancer.
Thyroid
2019
30350351
Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.
Int J Cancer
2019
30654714
Risk Haplotypes Uniquely Associated with Radioiodine-Refractory Thyroid Cancer Patients of High African Ancestry.
Thyroid
2019
29121253
The Role of NRG1 in the Predisposition to Papillary Thyroid Carcinoma.
J Clin Endocrinol Metab
2018
30143619
NF-κB inhibition rescues cardiac function by remodeling calcium genes in a Duchenne muscular dystrophy model.
Nat Commun
2018
29300379
The role of SMAD3 in the genetic predisposition to papillary thyroid carcinoma.
Genet Med
2018
29027612
Penetrance of a rare familial mutation predisposing to papillary thyroid cancer.
Fam Cancer
2018
28031538
Variants in microRNA genes in familial papillary thyroid carcinoma.
Oncotarget
2017
28195142
A genome-wide association study yields five novel thyroid cancer risk loci.
Nat Commun
2017
27978560
Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.
JAMA Oncol
2017
26745718
HABP2 G534E Variant in Papillary Thyroid Carcinoma.
PLoS One
2016
27354268
Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid Leukemia.
Cancer Discov
2016
27342578
Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.
Thyroid
2016
27459529
Genome-Wide Expression Screening Discloses Long Noncoding RNAs Involved in Thyroid Carcinogenesis.
J Clin Endocrinol Metab
2016
26777211
An NF-κB--EphrinA5-Dependent Communication between NG2(+) Interstitial Cells and Myoblasts Promotes Muscle Growth in Neonates.
Dev Cell
2016
25303483
Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2.
J Clin Endocrinol Metab
2015
26274343
PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression.
J Clin Endocrinol Metab
2015
26582795
MicroRNA-3151 inactivates TP53 in BRAF-mutated human malignancies.
Proc Natl Acad Sci U S A
2015
26470881
Gene expression profiling of the human natural killer cell response to Fc receptor activation: unique enhancement in the presence of interleukin-12.
BMC Med Genomics
2015
26135620
A germline mutation in SRRM2, a splicing factor gene, is implicated in papillary thyroid carcinoma predisposition.
Sci Rep
2015
25918370
Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.
Proc Natl Acad Sci U S A
2015
24586049
NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformation.
Proc Natl Acad Sci U S A
2014
24586183
Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease.
PLoS Genet
2014
22577899
Recurrent and founder mutations in the PMS2 gene.
Clin Genet
2013
23690926
Ultra-rare mutation in long-range enhancer predisposes to thyroid carcinoma with high penetrance.
PLoS One
2013
23659773
Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma.
Thyroid
2013
23539728
SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility.
J Clin Endocrinol Metab
2013
21671475
An American founder mutation in MLH1.
Int J Cancer
2012
22916164
Suppression of peroxiredoxin 4 in glioblastoma cells increases apoptosis and reduces tumor growth.
PLoS One
2012
22929189
Inherited cobalamin malabsorption. Mutations in three genes reveal functional and ethnic patterns.
Orphanet J Rare Dis
2012
22529287
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia.
Blood
2012
22493267
Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia.
Proc Natl Acad Sci U S A
2012
22586128
The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.
Proc Natl Acad Sci U S A
2012
22351927
IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism.
J Cell Biol
2012
1 - 50 of 99
Column Actions
Search
Recommended Authors
Aurelie Vogt
Frederick National Laboratory for Cancer Research (FNLCR), Inc.
Career Start Year
2012
Number of shared co-authors
1
Qiyuan Li
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year
2008
Number of shared co-authors
7
Katayoon Kasaian
Ontario Institute for Cancer Research
Career Start Year
2008
Number of shared co-authors
0
Laurie Burdett
National Cancer Institute, Frederick National Laboratory for Cancer Research
Career Start Year
2005
Number of shared co-authors
2
Sudheer Kumar Gara
National Cancer Institute, National Institutes of Health
Career Start Year
2005
Number of shared co-authors
2
Francesca Rizzo
University of Salerno and Genome Research Center for Health
Career Start Year
2004
Number of shared co-authors
0
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year
2003
Number of shared co-authors
1
Yuelin J Zhu
National Cancer Institute, National Institutes of Health
Career Start Year
2002
Number of shared co-authors
1
Jorge Estefano Santana de Souza
Instituto Metropole Digital, Universidade Federal do Rio Grande do Norte
Career Start Year
2002
Number of shared co-authors
0
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year
2001
Number of shared co-authors
2
Yonghong Wang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
2001
Number of shared co-authors
1
Yan W Asmann
Mayo Clinic
Career Start Year
2000
Number of shared co-authors
1
Ru-Fang Yeh
Genentech Inc.
Career Start Year
1999
Number of shared co-authors
1
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year
1998
Number of shared co-authors
1
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
1997
Number of shared co-authors
1
Liang Wang
H. Lee Moffitt Cancer Center
Career Start Year
1996
Number of shared co-authors
5
Agnes Viale
Memorial Sloan Kettering Cancer Center
Career Start Year
1996
Number of shared co-authors
0
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year
1995
Number of shared co-authors
0
Marbin Pineda
Center for Cancer Research, National Cancer Institute
Career Start Year
1995
Number of shared co-authors
0
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year
1995
Number of shared co-authors
1
Alexei Protopopov
The University of MD Anderson Cancer Center
Career Start Year
1995
Number of shared co-authors
0
Yusuke Nakamura
Japanese Foundation for Cancer Research
Career Start Year
1992
Number of shared co-authors
19
Thomas J Hudson
Ontario Institute for Cancer Research
Career Start Year
1991
Number of shared co-authors
26
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year
1991
Number of shared co-authors
2
Ming-Hui Wei
Yantai Affiliated Hospital of Binzhou Medical University
Career Start Year
1991
Number of shared co-authors
0
Sean M Grimmond
The University of Melbourne
Career Start Year
1990
Number of shared co-authors
2
Wan L Lam
British Columbia Cancer Research Institute
Career Start Year
1987
Number of shared co-authors
0
Eivind Hovig
Center for Bioinformatics, University of Oslo
Career Start Year
1987
Number of shared co-authors
5
David A Wheeler
Baylor College of Medicine
Career Start Year
1984
Number of shared co-authors
10
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Career Start Year
1983
Number of shared co-authors
29
row(s) 1 - 30 of 30
Collaborators
Albert de la Chapelle
The Ohio State University Comprehensive Cancer Center
Co-authored papers
62
Huiling He
The Ohio State University Comprehensive Cancer Center
Co-authored papers
36
Wei Li
The Ohio State University
Co-authored papers
24
Ramana V Davuluri
The Wistar Institute
Co-authored papers
19
Rebecca Nagy
Guardant Health Inc.
Co-authored papers
18
Matthew D Ringel
The Ohio State University College of Medicine and Comprehensive Cancer Center
Co-authored papers
14
Tim H-M Huang
University of Texas Health San Antonio (UTHSA)
Co-authored papers
11
Krystian Jazdzewski
Biological and Chemical Research Centre, University of Warsaw
Co-authored papers
8
Ann-Kathrin Eisfeld
The Ohio State University Comprehensive Cancer Center
Co-authored papers
7
Christoph Plass
German Cancer Research Center
Co-authored papers
7
Keiko Akagi
The University of Texas MD Anderson Cancer Center
Co-authored papers
6
David E Symer
The University of Texas MD Anderson Cancer Center
Co-authored papers
6
Lambertus A Kiemeney
Co-authored papers
5
Kari Stefansson
University of Iceland
Co-authored papers
5
Lianbo Yu
The Ohio State University
Co-authored papers
5
Richard T Kloos
Veracyte Inc.
Co-authored papers
5
Krzysztof Mr??zek
The Ohio State Comprehensive Cancer Center
Co-authored papers
4
Bernard Wen
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
4
Gudmar Thorleifsson
deCODE genetics/Amgen Inc.
Co-authored papers
4
Michael C Ostrowski
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers
3
Aarno Palotie
Co-authored papers
3
Ting Xu
Jiangsu Food & Pharmaceutical Science College
Co-authored papers
3
Silvia Naitza
Co-authored papers
3
Anne R Cappola
Perelman School of Medicine at the University of Pennsylvania
Co-authored papers
3
Ma??gorzata Czetwerty??ska
Maria Sklodowska-Curie Institute - Oncology Centre
Co-authored papers
3
Serena Sanna
Co-authored papers
3
Robert Brown
Ovarian Cancer Action Research Centre, Imperial College London
Co-authored papers
3
Barbara Jarzab
M. Sklodowska-Curie National Research Institute of Oncology Gliwice Branch
Co-authored papers
3
Elzbieta Stachlewska
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
Co-authored papers
3
Motoyasu Saji
The Ohio State University School of Medicine
Co-authored papers
3
1 - 30